EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

Vlado Perkovic, Jonathan Barratt, Brad Rovin, Naoki Kashihara, Bart Maes, Hong Zhang, Hernán Trimarchi, Dmitrij Kollins, Olympia Papachristofi, Severina Jacinto-Sanders, Tobias Merkel, Nicolas Guerard und 4 weitere

New England Journal of Medicine · 06.02.2025 · 392 (6) · 531-543

DOI: 10.1056/nejmoa2410316 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 06.02.2025. Verfasst von Vlado Perkovic und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of New South Wales, Sydney. Hauptthemen laut MEDLINE: Complement Inactivating Agents, Complement Pathway, Alternative, Glomerulonephritis, IGA, Proteinuria. Die Arbeit wurde bisher 222-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Novartis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement Inactivating AgentsComplement Pathway, AlternativeGlomerulonephritis, IGAProteinuriaAdultFemaleHumansMaleMiddle AgedCreatinineDouble-Blind MethodRenal Replacement TherapyAdministration, OralTreatment OutcomeBenzoatesIndolesPiperidines

Substanzen

Complement Inactivating AgentsCreatinineiptacopanBenzoatesIndolesPiperidines

Autor:innen und Institutionen

  • University of New South Wales, Sydney.
  • The Mayer IgA Nephropathy Laboratories, University of Leicester, Leicester, United Kingdom.
  • Ohio State University Wexner Medical Center, Columbus.
  • Kawasaki Medical School, Okayama, Japan.
  • AZ Delta, Roeselare, Belgium.
  • Peking University First Hospital, Beijing.

Förderung

  • Novartis

Zitieren

APA

Perkovic, V., Barratt, J., Rovin, B., Kashihara, N., Maes, B., Zhang, H., Trimarchi, H., Kollins, D., Papachristofi, O., Jacinto-Sanders, S., Merkel, T., Guerard, N., Renfurm, R., Hach, T., Rizk, D. V., & APPLAUSE-IgAN Investigators (2025). Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy. New England Journal of Medicine, 392(6), 531-543. https://doi.org/10.1056/nejmoa2410316

Vancouver

Perkovic V, Barratt J, Rovin B, Kashihara N, Maes B, Zhang H, et al. Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy. New England Journal of Medicine. 2025;392(6):531-543. doi:10.1056/nejmoa2410316

BibTeX
@article{Perkovic2025,
  author = {Perkovic, Vlado and Barratt, Jonathan and Rovin, Brad and Kashihara, Naoki and Maes, Bart and Zhang, Hong and Trimarchi, Hernán and Kollins, Dmitrij and Papachristofi, Olympia and Jacinto-Sanders, Severina and Merkel, Tobias and Guerard, Nicolas and Renfurm, Ronny and Hach, Thomas and Rizk, Dana V and APPLAUSE-IgAN Investigators, APPLAUSE-IgAN Investigators},
  title = {Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {6},
  pages = {531--543},
  doi = {10.1056/nejmoa2410316}
}
Kostenlos starten →